A detailed history of Royce & Associates LP transactions in Enfusion, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 99,715 shares of ENFN stock, worth $991,167. This represents 0.01% of its overall portfolio holdings.

Number of Shares
99,715
Previous 73,670 35.35%
Holding current value
$991,167
Previous $627,000 50.72%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$7.89 - $9.69 $205,495 - $252,376
26,045 Added 35.35%
99,715 $945,000
Q2 2024

Aug 13, 2024

BUY
$8.15 - $9.78 $600,410 - $720,492
73,670 New
73,670 $627,000
Q1 2023

May 04, 2023

SELL
$10.07 - $12.1 $275,918 - $331,540
-27,400 Reduced 65.71%
14,300 $150,000
Q4 2022

May 23, 2023

BUY
$8.72 - $14.17 $238,928 - $388,258
27,400 Added 191.61%
41,700 $403,000
Q4 2022

Feb 13, 2023

BUY
$8.72 - $14.17 $363,624 - $590,889
41,700 New
41,700 $403,000

Others Institutions Holding ENFN

About Enfusion, Inc.


  • Ticker ENFN
  • Exchange NYSE
  • Sector Technology
  • Industry Software—Application
  • Shares Outstandng 67,001,700
  • Market Cap $666M
  • Description
  • Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or...
More about ENFN
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.